In Brief: Novartis Nutrition
This article was originally published in The Tan Sheet
Executive Summary
Novartis Nutrition: Clinical trials will investigate cholesterol-reduction potential of plant-based sterol composition "FCP," a wood pulp-derived "potential functional food ingredient" that the company has an exclusive option to license from Vancouver-based Forbes Medi-Tech. The Medi-Tech agreement is a "first step" in Novartis' "science-based nutrition strategy," according to Novartis Nutrition...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: